Nasal eosinophilia induced by PAF-acether is accompanied by the release of eosinophil cationic protein

A. Tedeschi, N. Milazzo, A. Miadonna

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

It has been demonstrated that platelet-activating factor (PAF)-acether can induce nasal neutrophilia and eosinophilia, with a different degree of responsiveness in atopic and in nonatopic subjects. The aim of this study was to evaluate whether PAF can also induce the release of secondary mediators in the human nose Ten patients with allergic rhinitis and 10 normal subjects underwent nasal challenge with PAP (500 nmol), lyso-PAF (500 nmol) and saline solution. Nasal lavages were performed before and after challenge to evaluate changes in nasal cytology and release of histamine, immunoreactive leukotriene (iLT) C4 and eosinophil cationic protein (ECP). PAF caused neutrophilia and eosinophilia, which appeared earlier in atopic than in nonatopic subjects (30 min vs 1 h), and peaked 3 h after challenge in both groups. Lyso-PAF caused mild neutrophilia, which appeared 3 h after challenge in both groups; an increase in eosinophil counts was observed 3 h after challenge in atopic subjects, but not in nonatopic subjects. PAF insufflation caused a significant release of ECP in nasal lavage fluids 30 min and 3h after challenge in atopic subjects, and 3 h after challenge in nonatopic subjects. ECP levels in the nasal lavages collected 30 min and 3 h after challenge with PAP were higher in atopic than in nonatopic subjects. Eosinophil counts correlated with ECP levels in the nasal lavages collected 30 min after PAF challenge in atopic subjects. Nasal challenge with lyso-PAF did not provoke any release of ECP. No significant increase of histamine and iLTC4 levels in nasal lavages was found after challenge with either PAF or lyso-PAF: These results indicate that PAF-induced nasal eosinophilia is accompanied by ECP release, which appears earlier and is more marked in atopic than in nonatopic subjects.

Original languageEnglish
Pages (from-to)1445-1451
Number of pages7
JournalEuropean Respiratory Journal
Volume7
Issue number8
Publication statusPublished - 1994

Fingerprint

Eosinophil Cationic Protein
Platelet Activating Factor
Eosinophilia
Nose
Nasal Lavage
Eosinophils
Nasal Lavage Fluid
Leukotriene C4
Insufflation
Histamine Release
Sodium Chloride
Histamine
Cell Biology
O-deacetyl platelet activating factor

Keywords

  • Eosinophil cationic protein
  • Lyso-PAF
  • Nasal lavage
  • Platelet-activating factor (PAF)

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine

Cite this

Nasal eosinophilia induced by PAF-acether is accompanied by the release of eosinophil cationic protein. / Tedeschi, A.; Milazzo, N.; Miadonna, A.

In: European Respiratory Journal, Vol. 7, No. 8, 1994, p. 1445-1451.

Research output: Contribution to journalArticle

Tedeschi, A. ; Milazzo, N. ; Miadonna, A. / Nasal eosinophilia induced by PAF-acether is accompanied by the release of eosinophil cationic protein. In: European Respiratory Journal. 1994 ; Vol. 7, No. 8. pp. 1445-1451.
@article{775b6bd837ed4418a1f583eb83d7d2ac,
title = "Nasal eosinophilia induced by PAF-acether is accompanied by the release of eosinophil cationic protein",
abstract = "It has been demonstrated that platelet-activating factor (PAF)-acether can induce nasal neutrophilia and eosinophilia, with a different degree of responsiveness in atopic and in nonatopic subjects. The aim of this study was to evaluate whether PAF can also induce the release of secondary mediators in the human nose Ten patients with allergic rhinitis and 10 normal subjects underwent nasal challenge with PAP (500 nmol), lyso-PAF (500 nmol) and saline solution. Nasal lavages were performed before and after challenge to evaluate changes in nasal cytology and release of histamine, immunoreactive leukotriene (iLT) C4 and eosinophil cationic protein (ECP). PAF caused neutrophilia and eosinophilia, which appeared earlier in atopic than in nonatopic subjects (30 min vs 1 h), and peaked 3 h after challenge in both groups. Lyso-PAF caused mild neutrophilia, which appeared 3 h after challenge in both groups; an increase in eosinophil counts was observed 3 h after challenge in atopic subjects, but not in nonatopic subjects. PAF insufflation caused a significant release of ECP in nasal lavage fluids 30 min and 3h after challenge in atopic subjects, and 3 h after challenge in nonatopic subjects. ECP levels in the nasal lavages collected 30 min and 3 h after challenge with PAP were higher in atopic than in nonatopic subjects. Eosinophil counts correlated with ECP levels in the nasal lavages collected 30 min after PAF challenge in atopic subjects. Nasal challenge with lyso-PAF did not provoke any release of ECP. No significant increase of histamine and iLTC4 levels in nasal lavages was found after challenge with either PAF or lyso-PAF: These results indicate that PAF-induced nasal eosinophilia is accompanied by ECP release, which appears earlier and is more marked in atopic than in nonatopic subjects.",
keywords = "Eosinophil cationic protein, Lyso-PAF, Nasal lavage, Platelet-activating factor (PAF)",
author = "A. Tedeschi and N. Milazzo and A. Miadonna",
year = "1994",
language = "English",
volume = "7",
pages = "1445--1451",
journal = "European Journal of Respiratory Diseases",
issn = "0903-1936",
publisher = "European Respiratory Society",
number = "8",

}

TY - JOUR

T1 - Nasal eosinophilia induced by PAF-acether is accompanied by the release of eosinophil cationic protein

AU - Tedeschi, A.

AU - Milazzo, N.

AU - Miadonna, A.

PY - 1994

Y1 - 1994

N2 - It has been demonstrated that platelet-activating factor (PAF)-acether can induce nasal neutrophilia and eosinophilia, with a different degree of responsiveness in atopic and in nonatopic subjects. The aim of this study was to evaluate whether PAF can also induce the release of secondary mediators in the human nose Ten patients with allergic rhinitis and 10 normal subjects underwent nasal challenge with PAP (500 nmol), lyso-PAF (500 nmol) and saline solution. Nasal lavages were performed before and after challenge to evaluate changes in nasal cytology and release of histamine, immunoreactive leukotriene (iLT) C4 and eosinophil cationic protein (ECP). PAF caused neutrophilia and eosinophilia, which appeared earlier in atopic than in nonatopic subjects (30 min vs 1 h), and peaked 3 h after challenge in both groups. Lyso-PAF caused mild neutrophilia, which appeared 3 h after challenge in both groups; an increase in eosinophil counts was observed 3 h after challenge in atopic subjects, but not in nonatopic subjects. PAF insufflation caused a significant release of ECP in nasal lavage fluids 30 min and 3h after challenge in atopic subjects, and 3 h after challenge in nonatopic subjects. ECP levels in the nasal lavages collected 30 min and 3 h after challenge with PAP were higher in atopic than in nonatopic subjects. Eosinophil counts correlated with ECP levels in the nasal lavages collected 30 min after PAF challenge in atopic subjects. Nasal challenge with lyso-PAF did not provoke any release of ECP. No significant increase of histamine and iLTC4 levels in nasal lavages was found after challenge with either PAF or lyso-PAF: These results indicate that PAF-induced nasal eosinophilia is accompanied by ECP release, which appears earlier and is more marked in atopic than in nonatopic subjects.

AB - It has been demonstrated that platelet-activating factor (PAF)-acether can induce nasal neutrophilia and eosinophilia, with a different degree of responsiveness in atopic and in nonatopic subjects. The aim of this study was to evaluate whether PAF can also induce the release of secondary mediators in the human nose Ten patients with allergic rhinitis and 10 normal subjects underwent nasal challenge with PAP (500 nmol), lyso-PAF (500 nmol) and saline solution. Nasal lavages were performed before and after challenge to evaluate changes in nasal cytology and release of histamine, immunoreactive leukotriene (iLT) C4 and eosinophil cationic protein (ECP). PAF caused neutrophilia and eosinophilia, which appeared earlier in atopic than in nonatopic subjects (30 min vs 1 h), and peaked 3 h after challenge in both groups. Lyso-PAF caused mild neutrophilia, which appeared 3 h after challenge in both groups; an increase in eosinophil counts was observed 3 h after challenge in atopic subjects, but not in nonatopic subjects. PAF insufflation caused a significant release of ECP in nasal lavage fluids 30 min and 3h after challenge in atopic subjects, and 3 h after challenge in nonatopic subjects. ECP levels in the nasal lavages collected 30 min and 3 h after challenge with PAP were higher in atopic than in nonatopic subjects. Eosinophil counts correlated with ECP levels in the nasal lavages collected 30 min after PAF challenge in atopic subjects. Nasal challenge with lyso-PAF did not provoke any release of ECP. No significant increase of histamine and iLTC4 levels in nasal lavages was found after challenge with either PAF or lyso-PAF: These results indicate that PAF-induced nasal eosinophilia is accompanied by ECP release, which appears earlier and is more marked in atopic than in nonatopic subjects.

KW - Eosinophil cationic protein

KW - Lyso-PAF

KW - Nasal lavage

KW - Platelet-activating factor (PAF)

UR - http://www.scopus.com/inward/record.url?scp=0028088036&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028088036&partnerID=8YFLogxK

M3 - Article

VL - 7

SP - 1445

EP - 1451

JO - European Journal of Respiratory Diseases

JF - European Journal of Respiratory Diseases

SN - 0903-1936

IS - 8

ER -